Inventor · disambiguated record
Jason Kropp
Also filed as: KROPP JASON · KROPP JASON T
7 granted patents·5 pending applications·33 citations·filing 2012–2024
81Inventor score
Top patents by PatentIndex Score
12 records- 0193US8809349B2Processes for preparing isoquinolinones and solid forms of isoquinolinonesREN PINGDA·Filed 2012·Granted Aug 19, 2014·26 cites·65 claims
- 0286US9290497B2Processes for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Mar 22, 2016·6 cites·37 claims
- 0386US2025197400A1Processes for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0483US11312718B2Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-oneINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Apr 26, 2022·1 cites·34 claims
- 0577US2023108157A1Formulations of (s)-3-(1-(9h-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2h)-oneINFINITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0667US10550122B2Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Feb 4, 2020·0 cites·31 claims
- 0764US2024317771A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2024·Application pending·0 cites
- 0862US12043626B2Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2022·Granted Jul 23, 2024·0 cites·36 claims
- 0962US9840505B2Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Dec 12, 2017·0 cites·31 claims
- 1061USRE46621EProcesses for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Dec 5, 2017·0 cites·66 claims
- 1160US2025339412A1Methods of treating solid tumor using (19r)-5-chloro-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,10,11,23-pentaazapentacyclo[19.3.1.02,6.08,12.013,18]pentacosa-1(24),2(6),4,8,11,13,15,17,21(25),22-decaen-22-amineNUVALENT INC·Filed 2023·Application pending·0 cites
- 1250US2023322797A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Kropp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →